Global trends in molecular epidemiology of HIV-1 during 2000-2007

AIDS

Volumn 25, Issue 5, 2011, Pages 679-689

  Hemelaar, Joris ^a   Gouws, Eleanor ^b   Ghys, Peter D ^b   Osmanov, Saladin ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNAIDS   (Switzerland)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

circulating recombinant form; HIV; molecular epidemiology; recombinant; subtype; vaccine

Indexed keywords

ARTICLE; ASIA; CENTRAL AFRICA; CENTRAL AMERICA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EASTERN EUROPE; ETHIOPIA; GEOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INDIA; MAJOR CLINICAL STUDY; MIDDLE EAST; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NORTH AFRICA; NORTH AMERICA; PACIFIC ISLANDS; PANDEMIC; PRIORITY JOURNAL; SOUTH AFRICA; SOUTH AND CENTRAL AMERICA; VIRUS RECOMBINANT; VIRUS TYPING; WESTERN EUROPE;

CROSS-SECTIONAL STUDIES; FEMALE; GENETIC VARIATION; HIV INFECTIONS; HIV-1; HUMANS; MALE; MOLECULAR EPIDEMIOLOGY; RECOMBINATION, GENETIC; SEROTYPING; WORLD HEALTH;

EID: 79952414942     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328342ff93     Document Type: Article

References (28)

1. UNAIDS. AIDS epidemic update 2009. Geneva: UNAIDS; 2009.
2. Keele BF, Van Heuverswyn F, Li Y, Bailes E, Takehisa J, Santiago ML, et al. Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science 2006; 313:523-526. (Pubitemid 44148457)
3. Worobey M, Gemmel M, Teuwen DE, Haselkorn T, Kunstman K, Bunce M, et al. Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature 2008; 455:661-664.
4. Robertson DL, Anderson JP, Bradac JA, Carr JK, Foley B, Funkhouser RK, et al. HIV-1 nomenclature proposal. Science 2000; 288:55-56.
5. Hemelaar J, Gouws E, Ghys PD, Osmanov S. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 2006; 20:W13-W23. (Pubitemid 44611051)
6. Plantier JC, Leoz M, Dickerson JE, De Oliveira F, Cordonnier F, Lemee V, et al. A new human immunodeficiency virus derived from gorillas. Nat Med 2009; 15:871-872.
7. Kim JE, Beckthold B, Chen Z, Mihowich J, Malloch L, Gill MJ. Short communication: identification of a novel HIV type 1 subtype H/J recombinant in Canada with discordant HIV viral load (RNA) values in three different commercial assays. AIDS Res Hum Retroviruses 2007; 23:1309-1313.
8. Geretti AM, Harrison L, Green H, Sabin C, Hill T, Fearnhill E, et al. Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy. Clin Infect Dis 2009; 48:1296-1305.
9. Martinez-Cajas JL, Pai NP, Klein MB, Wainberg MA. Differences in resistance mutations among HIV-1 nonsubtype B infections: a systematic review of evidence (1996-2008). J Int AIDS Soc 2009; 12:11.
10. Kiwanuka N, Laeyendecker O, Robb M, Kigozi G, Arroyo M, McCutchan F, et al. Effect of human immunodeficiency virus type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J Infect Dis 2008; 197:707-713. (Pubitemid 351364471)
11. Baeten JM, Chohan B, Lavreys L, Chohan V, McClelland RS, Certain L, et al. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis 2007; 195:1177-1180. (Pubitemid 46543449)
12. Vasan A, Renjifo B, Hertzmark E, Chaplin B, Msamanga G, Essex M, et al. Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Clin Infect Dis 2006; 42:843-852. (Pubitemid 43363943)
13. Kiwanuka N, Laeyendecker O, Quinn TC, Wawer MJ, Shepherd J, Robb M, et al. HIV-1 subtypes and differences in heterosexual HIV transmission among HIV-discordant couples in Rakai, Uganda. AIDS 2009; 23:2479-2484.
14. Renjifo B, Gilbert P, Chaplin B, Msamanga G, Mwakagile D, Fawzi W, et al. Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D. AIDS 2004; 18:1629-1636. (Pubitemid 39095779)
15. Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, et al. Antibody neutralization and escape by HIV-1. Nature 2003; 422:307-312. (Pubitemid 36378357)
16. Goonetilleke N, Liu MK, Salazar-Gonzalez JF, Ferrari G, Giorgi E, Ganusov VV, et al. The first T cell response to transmitted/ founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med 2009; 206:1253-1272.
17. Barouch DH. Challenges in the development of an HIV-1 vaccine. Nature 2008; 455:613-619.
18. Korber B, Gaschen B, Yusim K, Thakallapally R, Kesmir C, Detours V. Evolutionary and immunological implications of contemporary HIV-1 variation. Br Med Bull 2001; 58:19-42. (Pubitemid 33070762)
19. Lee JK, Stewart-Jones G, Dong T, Harlos K, Di Gleria K, Dorrell L, et al. T cell cross-reactivity and conformational changes during TCR engagement. J Exp Med 2004; 200:1455-1466. (Pubitemid 39657293)
20. Gaschen B, Taylor J, Yusim K, Foley B, Gao F, Lang D, et al. Diversity considerations in HIV-1 vaccine selection. Science 2002; 296:2354-2360. (Pubitemid 34734202)
21. Pitisuttithum P, Gilbert P, Gurwith M, Heyward W, Martin M, van Griensven F, et al. Randomized, double-blind, placebocontrolled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J Infect Dis 2006; 194:1661-1671. (Pubitemid 44901996)
22. Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 2008; 372: 1881-1893.
23. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009; 361:2209-2220.
24. Arien KK, Vanham G, Arts EJ. Is HIV-1 evolving to a less virulent form in humans? Nat Rev Microbiol 2007; 5:141-151. (Pubitemid 46151872)
25. UNAIDS. Report on the global AIDS epidemic. Geneva: UNAIDS, 2008.
26. Rainwater S, DeVange S, Sagar M, Ndinya-Achola J, Mandaliya K, Kreiss JK, et al. No evidence for rapid subtype C spread within an epidemic in which multiple subtypes and intersubtype recombinants circulate. AIDS Res Hum Retroviruses 2005; 21:1060-1065. (Pubitemid 43069191)
27. Gray RR, Tatem AJ, Lamers S, Hou W, Laeyendecker O, Serwadda D, et al. Spatial phylodynamics of HIV-1 epidemic emergence in east Africa. AIDS 2009; 23:F9-F17.
28. Corey L, McElrath MJ. HIV vaccines: mosaic approach to virus diversity. Nat Med 2010; 16:268-270.